Jurgen Barth
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas (NCT00877214) | Jurgen Barth | 2009-04-01 |
| Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab (NCT02157181) | Jurgen Barth | 2004-06-01 |
Track Jurgen Barth automatically
Every clearance here is in the API, with alerts when new ones post.